A gut check: understanding the interplay of the gastrointestinal microbiome and the developing immune system towards the goal of pediatric HIV remission.
Nicole Soo, Omotayo Farinre, Ann Chahroudi, Saikat Boliar, Ria Goswami
{"title":"A gut check: understanding the interplay of the gastrointestinal microbiome and the developing immune system towards the goal of pediatric HIV remission.","authors":"Nicole Soo, Omotayo Farinre, Ann Chahroudi, Saikat Boliar, Ria Goswami","doi":"10.1186/s12977-024-00648-9","DOIUrl":null,"url":null,"abstract":"<p><p>Despite the efficacy of antiretroviral therapy (ART) in reducing the global incidence of vertical HIV transmissions, more than 120,000 children are still infected with the virus each year. Since ART cannot clear the HIV reservoir that is established soon after infection, children living with HIV (CLWH) are forced to rely on therapy for their lives and suffer from long-term drug-related complications. Pediatric HIV infection, like adult infection, is associated with gut microbial dysbiosis, loss of gut epithelial integrity, bacterial translocation, CD4 + T cell depletion, systemic immune activation, and viral reservoir establishment. However, unlike in adults, HIV that is vertically acquired by infants interacts with a gut microbiome that is continuously evolving while concomitantly shaping the infant's immune ontogeny. Therefore, to determine whether there may be interventions that target the HIV reservoir through microbiome-directed approaches, understanding the complex tripartite interactions between the transmitted HIV, the maturing gut microbiome, and the developing immune system during early life is crucial. Importantly, early life is the time when the gut microbiome of an individual is highly dynamic, and this temporal development of the gut microbiome plays a crucial role in educating the maturing immune system of a child. Therefore, manipulation of the gut microbiome of CLWH to a phenotype that can reduce HIV persistence by fostering an antiviral immune system might be an opportune strategy to achieve ART-free viral suppression in CLWH. This review summarizes the current state of knowledge on the vertical transmission of HIV, the developing gut microbiome of CLWH, and the immune landscape of pediatric elite controllers, and explores the prospect of employing microbial modulation as a potential therapeutic approach to achieve ART-free viral suppression in the pediatric population.</p>","PeriodicalId":21123,"journal":{"name":"Retrovirology","volume":"21 1","pages":"15"},"PeriodicalIF":2.7000,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11490017/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Retrovirology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12977-024-00648-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Despite the efficacy of antiretroviral therapy (ART) in reducing the global incidence of vertical HIV transmissions, more than 120,000 children are still infected with the virus each year. Since ART cannot clear the HIV reservoir that is established soon after infection, children living with HIV (CLWH) are forced to rely on therapy for their lives and suffer from long-term drug-related complications. Pediatric HIV infection, like adult infection, is associated with gut microbial dysbiosis, loss of gut epithelial integrity, bacterial translocation, CD4 + T cell depletion, systemic immune activation, and viral reservoir establishment. However, unlike in adults, HIV that is vertically acquired by infants interacts with a gut microbiome that is continuously evolving while concomitantly shaping the infant's immune ontogeny. Therefore, to determine whether there may be interventions that target the HIV reservoir through microbiome-directed approaches, understanding the complex tripartite interactions between the transmitted HIV, the maturing gut microbiome, and the developing immune system during early life is crucial. Importantly, early life is the time when the gut microbiome of an individual is highly dynamic, and this temporal development of the gut microbiome plays a crucial role in educating the maturing immune system of a child. Therefore, manipulation of the gut microbiome of CLWH to a phenotype that can reduce HIV persistence by fostering an antiviral immune system might be an opportune strategy to achieve ART-free viral suppression in CLWH. This review summarizes the current state of knowledge on the vertical transmission of HIV, the developing gut microbiome of CLWH, and the immune landscape of pediatric elite controllers, and explores the prospect of employing microbial modulation as a potential therapeutic approach to achieve ART-free viral suppression in the pediatric population.
尽管抗逆转录病毒疗法(ART)能有效降低全球艾滋病垂直传播的发病率,但每年仍有超过 12 万名儿童感染病毒。由于抗逆转录病毒疗法无法清除感染后不久形成的艾滋病病毒库,感染艾滋病病毒的儿童(CLWH)不得不终身依赖治疗,并长期遭受与药物相关的并发症的折磨。小儿艾滋病病毒感染与成人感染一样,与肠道微生物菌群失调、肠道上皮完整性丧失、细菌易位、CD4 + T 细胞耗竭、全身免疫激活和病毒库建立有关。然而,与成人不同的是,婴儿垂直感染的艾滋病病毒与肠道微生物群相互作用,而肠道微生物群在不断演变的同时也在塑造婴儿的免疫本体。因此,要确定是否有可能通过以微生物组为导向的方法针对艾滋病病毒库进行干预,了解生命早期传播的艾滋病病毒、成熟的肠道微生物组和发育中的免疫系统之间复杂的三方相互作用至关重要。重要的是,生命早期是个体肠道微生物组高度动态的时期,而肠道微生物组的这种时间性发展在教育儿童发育成熟的免疫系统方面起着至关重要的作用。因此,通过培养抗病毒免疫系统将儿童慢性淋巴细胞白血病患者的肠道微生物组调控到可减少艾滋病病毒持续存在的表型,可能是实现儿童慢性淋巴细胞白血病患者无抗病毒疗法病毒抑制的一个恰当策略。本综述总结了目前有关 HIV 垂直传播、CLWH 正在发育的肠道微生物组和儿科精英控制者免疫系统的知识,并探讨了将微生物调节作为一种潜在的治疗方法在儿科人群中实现无抗逆转录病毒疗法病毒抑制的前景。
期刊介绍:
Retrovirology is an open access, online journal that publishes stringently peer-reviewed, high-impact articles on host-pathogen interactions, fundamental mechanisms of replication, immune defenses, animal models, and clinical science relating to retroviruses. Retroviruses are pleiotropically found in animals. Well-described examples include avian, murine and primate retroviruses.
Two human retroviruses are especially important pathogens. These are the human immunodeficiency virus, HIV, and the human T-cell leukemia virus, HTLV. HIV causes AIDS while HTLV-1 is the etiological agent for adult T-cell leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesis. Retrovirology aims to cover comprehensively all aspects of human and animal retrovirus research.